CROVARI, PIETRO
 Distribuzione geografica
Continente #
EU - Europa 11.712
AS - Asia 35
SA - Sud America 26
Totale 11.773
Nazione #
IT - Italia 11.712
CN - Cina 18
BR - Brasile 17
VN - Vietnam 12
ID - Indonesia 3
VE - Venezuela 3
AR - Argentina 2
EC - Ecuador 2
AM - Armenia 1
IQ - Iraq 1
PY - Paraguay 1
UY - Uruguay 1
Totale 11.773
Città #
Genova 6.920
Genoa 2.659
Rapallo 1.238
Vado Ligure 875
Bordighera 20
Beijing 7
Hanoi 4
Quito 2
Thái Nguyên 2
Araure 1
Asunción 1
Belo Horizonte 1
Biên Hòa 1
Brasília 1
Cananéia 1
Capivari 1
Caracas 1
Carapicuíba 1
Caruaru 1
Chopinzinho 1
Criciúma 1
Cubatão 1
Haiphong 1
Ho Chi Minh City 1
Ipatinga 1
Itabuna 1
Jakarta 1
Louveira 1
Manaus 1
Maracay 1
Montevideo 1
Pilar 1
Quatá 1
Quảng Ngãi 1
Quận Bình Thạnh 1
Rio de Janeiro 1
Rosario 1
Thái Bình 1
Viamão 1
Vitória 1
Totale 11.758
Nome #
Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis 191
Epidemiological trend in tuberculosis in the Italian region of Liguria: impact of immigration and AIDS. 185
Evaluation of performance of RIBA processor system for automated analysis of the strip immunoblot assay for detection of antibodies to hepatitis C virus 147
Analytical and laboratory evaluation of a new fully-automated third generation enzyme immunoassay for the detection of antibodies to the hepatitis C virus 144
Socioeconomic impact of Influenza on healthy children and their families 144
SARS-CoV, influenza A and syncitial respiratory virus resistance against common disinfectants and ultraviolet irradiation 144
Clinical and socio-economic impact of influenza and respiratory syncytial virus infection on healthy children and their households 133
DIET AND ANTIBODY RESPONSE TO VACCINATION IN HEALTLY INFANTS 131
An outbreak of hepatitis C virus in a haemodialysis unit: molecular evidence of patient-to-patient transmission 131
Characterization of hepatitis C virus genotypes in Italian subjects at different risk of infection. 129
New A/H3N2 influenza variant: a small genetic evolution but a heavy burden on the Italian population during the 2004-2005 season 126
Benefit-cost evaluation of Influenza vaccination in the elderly in the Italian Region of Liguria 125
Surveillance of influenza in Apulia, Italy, 1999-2000, 2000-2001, 2001-2002 and 2002-2003 seasons 124
Molecular epidemiology of an outbreak of hepatitis A in Italy. 123
High heterogeneity of influenza B viruses circulating in Northern Italy during the 2001/2002 and 2002/2003 seasons 120
Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the Italian population 120
The intradermal vaccination: past experiences and current perspectives. 119
[Course of immunity in subjects repeatedly vaccinated with Sabin virus]. 119
Influenza Burden on Italian Paediatric Population: Five year Nation-wide Surveillance and Correlation between Epidemiological and Virological Data 117
Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains 117
Anamnestic response to administration of purified non-adsorbent hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres. 111
Influenza e Virus Respiratorio Sinciziale in età pediatrica: rischio di ospedalizzazione e caratteristiche dei ceppi circolanti. 110
Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy 110
Silver zeolite antimicrobial activity in aluminium heating, ventilation and air conditioning system ducts. 108
A novel approach to reduce the hepatitis C virus window period: clinical evaluation of a new ELISA assay for HCV core antigen 106
Molecular characterization of influenza B viruses circulating in Northeren Italy during the 2001-2002 epidemic season 106
[Detection of poliovirus carriers in the school population of Genoa, Savona and Alessandria from 1965 to 1969]. 106
Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses 104
Seroneutralization vs. Immunoenzymatic (ELISA) test: instruments for assessing humoral immunity towards the mumps virus. Preliminary results 104
Benefit-cost evaluation of Influenza vaccination in elderly people in Liguria, Italy 104
SERONEUTRALIZATION AND E.L.I.S.A. ASSAYS AS TOOLS FOR EVALUATION OF HUMORAL IMMUNITY TO MUMPS VIRUS 103
Impact of infant pneumococcal vaccination on pneumonia and acute otitis media hospitalisations in Liguria, Italy 101
Study for the improvement of antitetanus passive immunoprophylaxis and comparison between methods for antitoxin determination 101
Combination hepatitis C virus antigen and antibody immoassay as new tool for early diagnosis of infection 99
Use of a microplate method of enzyme-linked immunosorbent assay to detect serum antibody presence to influenza virus surface antigens 98
A/H1N1v influenza pandemic in Italy: an update 97
[Results of vaccination against influenza in a geriatric center. II. Epidemiological and clinical studies]. 96
Patient information, attitude and behaviour concerning influenza vaccination at the polyclinic of Siena 96
Phylogenetic relationships of the hemagglutinin and neuraminidase genes of human influenza B viruses isolated in Italy during the 2001-02 and 2002-03 seasons 93
La scelta dei ceppi da includere nel vaccino antinfluenzale: un nuovo test di microneutralizzazione per la valutazione dell’antigenicità e della suscettibilità della popolazione 93
First aid healthcare interventions Operations Centres (118) in Italy 92
Drug resistance among influenza A viruses isolated in Italy from 2000 to 2005: are the emergence of Adamantane-resistant viruses cause of concern? 91
The impact of Influenza and respiratory Syncitial virus in a 0-14 year children cohort: a comparison with the national surveillance network and between methods for influenza virological surveillance 91
Flaccid paralysis surveillance in the Italian region of Liguria 90
Weekly monitoring of Influenza Like Illness (ILI) and other acute respiratory infections (ARI) impact on pediatric population during the last two years in 10 Italian Regions. 90
Hospital Acquired Infections in Liguria. Prevalence, Location, Epidemiological monitoring Proposal in Medical Divisions 90
Influenza laboratory surveillance in 2000-01 and 2001-02 seasons in Italy: report on WHO national Influenza Center activity 88
Tubercolosis today: populations at risk 88
Pandemic Influenza Preparedness Plans 87
History and evolution of influenza vaccines 86
Influenza surveillance by general practitioners and paediatricians in the Italian region of Liguria in 1999-2002 86
The virological monitoring of water. I. Drinking water. 85
Quantitative detection and typing of HBs Ag and anti-HBs by radioimmunoassay techniques. 84
Evaluation of a new hepatitis C virus sequecing assay as a routine method for genotyping 84
Valutazione costi-benefici della vaccinazione influenzale in Liguria 83
Meningitis epidemiology: a review 83
Health care workers: their knowledge and behaviour with respect to influenza vaccination 83
Burden dell’influenza nella popolazione italiana nel periodo compreso tra il 1999 e il 2004: correlazioni tra sorveglianza clinico-epidemiologica e caratterizzazione antigenica e molecolare dei virus influenzali 83
Epidemiology of HDV Infection in Ligurian population 83
Purification of Influenza B virus haemagglutinin by Isoelectric Focusing 82
Fattori di rischio, stili di vita e prevenzione 81
Quantitative evaluation of anti-HBs in sera. II 81
Quantitative evaluation of anti-HBs in sera. I 81
Vaccinazione anti-influenzale: i vantaggi dei carrier di nuova generazione 81
Confronto fra metodiche sierologiche per la valutazione dello stato immunitario e l'accertamento dell'infezione rubeolica in gravidanza 80
The Thousand and One Antigenical and Virological faces of Influenza B Virus: Ten Years of Surveillance in Italy 80
Costi benefici della vaccinazione influenzale nella popolazione anziana genovese 80
Cinetica dell'antitossina tetanica dopo somministrazione di immunoglobuline specifiche 79
Influenza pandemic AH1N1V/2009. Early experience and autumn perspectives. 78
Influenza vaccination coverage levels among children with high-risk medical conditions 77
Immunogenicity of heptavalent pneumococcal vaccine and hexavalent vaccine, co-administered to italian infants at 3, 5 and 11-12 months of age 76
Vaccination promotion within a framework of public health education 76
Passive-active immunoprophylaxis in new-borns to HBsAg carrier Mothers in Liguria. I 76
Serological Protection Induced by Influenza Inactivated Vaccine Against Drifted Variants: The Importance of Adjuvant MF-59 76
Caratterizzazione molecolare dell'emoagglutinina dei virus influenzali B isolati nel corso della stagione epidemica 2001/02 76
Balneazione e malattie infettive - Indagine su un campione di scolari genovesi 76
Valutazione della copertura antinfluenzale in Liguria mediante somministrazione di questionario telefonico 75
Influenza epidemiology in Genoa between 1975 and 1978 74
Safety, Tolerability and Immunogenicity of two Influenza Subunit Vaccines, Combined and Not with MF-59 Adjuvant Emulsion, Administered to HIV-1 Seropositive and Seronegative Adults 73
Evaluation of safety, tolerability and immunogenicity of 6 licensed influenza vaccines 73
Influenza A, B and respiratory syncytial virus, a simultaneous detection by a new multiplex reverse transcription nested-PCR assay 73
Risposta sierologica a vaccini lievito-derivati contro l'epatite B 73
La vaccinazione antinfluenzale con vaccino a sub-unità nel primo anno di vita 73
Valutazione costi/benefici della vaccinazione influenzale negli anziani in Liguria (Italia) 73
Influenza-related hospitalizations, diagnostic procedures and medication use among healthy children and their families 71
Evaluation of antitetanus passive immunoprophylaxis and comparison between methods for antitoxin determination 71
Comportamento del titolo sierico dell'antitossina tetanica, somministrata per via intramuscolare e per via endovenosa. Confronto fra 2 metodi per il dosaggio in vitro 71
SARS Management 70
Bilancio del primo anno di vaccinazione contro l'epatite B in Liguria 70
Fattori di rischio, stili di vita e prevenzione 69
Epidemiological distribution and significance of anti-HBs. 69
Prime esperienze di vaccinazione contro l'epatite B a Genova: Risultati al 9^mese di follow-up 69
Balneazione e malattie infettive. Studio su 5576 scolari genovesi 69
Epidemiologia e prevenzione della poliomielite su basi molecolari 68
Malattie infettive 68
Poliomielite 67
Tra i vaccini facoltativi qualcuno merita l'obbligo 67
Determinazione delle IgM anticore, anti-delta e anti-HAV in soggetti HBsAg positivi ospedalizzati per Epatite acuta 66
L'epatite virale nel Comune di Genova 66
L’infezione da virus influenzale e quella da altri virus respiratori: differenze epidemiologiche 65
Totale 9.401
Categoria #
all - tutte 40.429
article - articoli 27.476
book - libri 0
conference - conferenze 8.880
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.073
Totale 80.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021262 0 0 0 6 18 44 12 16 65 27 39 35
2021/20221.452 12 162 118 210 25 37 72 381 38 127 54 216
2022/20231.468 164 87 12 137 273 292 6 134 243 9 100 11
2023/2024533 32 108 11 61 42 67 20 29 37 12 24 90
2024/20251.904 104 175 52 124 309 203 197 245 56 81 158 200
2025/2026946 338 100 181 327 0 0 0 0 0 0 0 0
Totale 11.809